Product Information
CLOZAPINE ODT 150 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $14.5428 per EA under NDC 00378381601. Its NADAC has been published 62 times since Apr 23, 2025.
Strength
150 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378381601
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA201824On Market Since
8/16/2023
Pharmacological Classes
Price Statistics
The NADAC for CLOZAPINE ODT 150 MG TABLET has been published 62 times since Apr 23, 2025, and over the history we have for it it has declined 14.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.5428 per EA |
|---|---|
| All-time high | $17.0568 (May 14, 2025) |
| All-time low | $14.1802 (May 20, 2026) |
| 52-week high | $16.9682 |
| 52-week low | $14.1802 |
| Median price | $15.4310 |
| Average price | $15.6509 |
| Largest weekly change | -7.7% (Jan 21, 2026) |
| Weeks tracked | 62 |
| Tracking since | Apr 23, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the clozapine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CLOZAPINE ODT 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOZAPINE ODT 150 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $14.5428 per EA (NDC 00378381601), effective Jun 24, 2026.
How has the price of CLOZAPINE ODT 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOZAPINE ODT 150 MG TABLET has declined 14.7%. It has been tracked across 62 weekly CMS publications since Apr 23, 2025.
What are the highest and lowest recorded NADAC prices for CLOZAPINE ODT 150 MG TABLET?
Since Apr 23, 2025, the NADAC for CLOZAPINE ODT 150 MG TABLET has ranged from a low of $14.1802 (May 20, 2026) to a high of $17.0568 (May 14, 2025), with a median of $15.4310 per EA.
Are there cheaper alternatives to CLOZAPINE ODT 150 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CLOZAPINE ODT 150 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures CLOZAPINE ODT 150 MG TABLET?
CLOZAPINE ODT 150 MG TABLET (NDC 00378381601) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification